{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:11:35Z","timestamp":1791209495518,"version":"4.1.0"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circ: Arrhythmia and Electrophysiology"],"published-print":{"date-parts":[[2009,10]]},"abstract":"<jats:p>\n            <jats:bold>\n              <jats:italic>Background\u2014<\/jats:italic>\n            <\/jats:bold>\n            <jats:italic>KCNJ2<\/jats:italic>\n            encodes Kir2.1, a pore-forming subunit of the cardiac inward rectifier current, I\n            <jats:sub>K1<\/jats:sub>\n            .\n            <jats:italic>KCNJ2<\/jats:italic>\n            mutations are associated with Andersen-Tawil syndrome and catecholaminergic polymorphic ventricular tachycardia. The aim of this study was to characterize the biophysical and cellular phenotype of a\n            <jats:italic>KCNJ2<\/jats:italic>\n            missense mutation, V227F, found in a patient with catecholaminergic polymorphic ventricular tachycardia.\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>\n              <jats:italic>Methods and Results\u2014<\/jats:italic>\n            <\/jats:bold>\n            Kir2.1-wild-type (WT) and V227F channels were expressed individually and together in Cos-1 cells to measure I\n            <jats:sub>K1<\/jats:sub>\n            by voltage clamp. Unlike typical Andersen-Tawil syndrome-associated\n            <jats:italic>KCNJ2<\/jats:italic>\n            mutations, which show dominant negative loss of function, Kir2.1WT+V227F coexpression yielded I\n            <jats:sub>K1<\/jats:sub>\n            indistinguishable from Kir2.1-WT under basal conditions. To simulate catecholamine activity, a protein kinase A (PKA)-stimulating cocktail composed of forskolin and 3-isobutyl-1-methylxanthine was used to increase PKA activity. This PKA-simulated catecholaminergic stimulation caused marked reduction of outward I\n            <jats:sub>K1<\/jats:sub>\n            compared with Kir2.1-WT. PKA-induced reduction in I\n            <jats:sub>K1<\/jats:sub>\n            was eliminated by mutating the phosphorylation site at serine 425 (S425N).\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>\n              <jats:italic>Conclusions\u2014<\/jats:italic>\n            <\/jats:bold>\n            Heteromeric Kir2.1-V227F and WT channels showed an unusual latent loss of function biophysical phenotype that depended on PKA-dependent Kir2.1 phosphorylation. This biophysical phenotype, distinct from typical Andersen-Tawil syndrome mutations, suggests a specific mechanism for PKA-dependent I\n            <jats:sub>K1<\/jats:sub>\n            dysfunction for this\n            <jats:italic>KCNJ2<\/jats:italic>\n            mutation, which correlates with adrenergic conditions underlying the clinical arrhythmia.\n          <\/jats:p>","DOI":"10.1161\/circep.109.872309","type":"journal-article","created":{"date-parts":[[2009,8,26]],"date-time":"2009-08-26T03:34:54Z","timestamp":1251257694000},"page":"540-547","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":59,"title":["Protein Kinase A-Dependent Biophysical Phenotype for V227F-KCNJ2 Mutation in Catecholaminergic Polymorphic Ventricular Tachycardia"],"prefix":"10.1161","volume":"2","author":[{"given":"Amanda L.","family":"Vega","sequence":"first","affiliation":[{"name":"From the Departments of Medicine (Cardiovascular Medicine) and Physiology (J.C.M.), University of Wisconsin (A.L.V.), Madison, Wis; the Departments of Medicine, Pediatrics, and Molecular Pharmacology and Experimental Therapeutics\/Divisions of Cardiovascular Diseases and Pediatric Cardiology (D.J.T., M.J.A.), Mayo Clinic, Rochester, Minn; and the Department of Physiology and Biophysics (A.L.V.), University of Washington, Seattle, Wash. Current address for Dr Vega is the Department of Physiology and..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Tester","sequence":"additional","affiliation":[{"name":"From the Departments of Medicine (Cardiovascular Medicine) and Physiology (J.C.M.), University of Wisconsin (A.L.V.), Madison, Wis; the Departments of Medicine, Pediatrics, and Molecular Pharmacology and Experimental Therapeutics\/Divisions of Cardiovascular Diseases and Pediatric Cardiology (D.J.T., M.J.A.), Mayo Clinic, Rochester, Minn; and the Department of Physiology and Biophysics (A.L.V.), University of Washington, Seattle, Wash. Current address for Dr Vega is the Department of Physiology and..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Ackerman","sequence":"additional","affiliation":[{"name":"From the Departments of Medicine (Cardiovascular Medicine) and Physiology (J.C.M.), University of Wisconsin (A.L.V.), Madison, Wis; the Departments of Medicine, Pediatrics, and Molecular Pharmacology and Experimental Therapeutics\/Divisions of Cardiovascular Diseases and Pediatric Cardiology (D.J.T., M.J.A.), Mayo Clinic, Rochester, Minn; and the Department of Physiology and Biophysics (A.L.V.), University of Washington, Seattle, Wash. Current address for Dr Vega is the Department of Physiology and..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan C.","family":"Makielski","sequence":"additional","affiliation":[{"name":"From the Departments of Medicine (Cardiovascular Medicine) and Physiology (J.C.M.), University of Wisconsin (A.L.V.), Madison, Wis; the Departments of Medicine, Pediatrics, and Molecular Pharmacology and Experimental Therapeutics\/Divisions of Cardiovascular Diseases and Pediatric Cardiology (D.J.T., M.J.A.), Mayo Clinic, Rochester, Minn; and the Department of Physiology and Biophysics (A.L.V.), University of Washington, Seattle, Wash. Current address for Dr Vega is the Department of Physiology and..."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.76.3.343"},{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(01)00342-7"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.res.0000162101.76263.8c"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2005.05.054"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1080\/17431380410032490"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.91.5.1512"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000020013.73106.d8"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.103.23.2822"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.res.0000038886.18992.6b"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.107.711689"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2006.03.025"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2006.10.025"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/329219a0"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.12.5819"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/humu.9483"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.85.9.803"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1540-8167.2003.02379.x"},{"key":"e_1_3_2_18_2","first-page":"2552","volume":"118","year":"2008","unstructured":"Amin AS, Herfst LJ, Delisle BP, Klemens CA, Rook MB, Bezzina CR, Underkofler HA, Holzem KM, Ruijter JM, Tan HL, January CT, Wilde AA. Fever-induced QTc prolongation and ventricular arrhythmias in individuals with type 2 congenital long QT syndrome. J Clin Invest. 2008; 118: 2552\u20132561.","journal-title":"J Clin Invest"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000132472.98675.ec"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI25618"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.106.646513"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0896-6273(94)90426-X"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00386.2003"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-7793.1997.545bd.x"},{"key":"e_1_3_2_25_2","first-page":"H506","volume":"268","year":"1995","unstructured":"Ashen MD, O'Rourke B, Kluge KA, Johns DC, Tomaselli GF. Inward rectifier K+ channel from human heart and brain: cloning and stable expression in a human cell line. Am J Physiol. 1995; 268: H506\u2013H511.","journal-title":"Am J Physiol"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-7793.2001.t01-1-00697.x"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3495(90)82422-X"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1995.sp020842"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118358"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.29.923"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1989.sp017720"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.88.11.1159"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00393.2006"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00701.2006"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2005.11.026"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardiores.2007.04.028"},{"key":"e_1_3_2_37_2","first-page":"66","volume":"25","year":"2004","unstructured":"Postma AV, Bhuiyan ZA, Shkolnikova M, Denjoy I, Mannens MM, Wilde AAM, Guicheney R, Bezzina CR. Involvement of the Kir2 gene family in catecholaminergic polymorphic ventricular tachycardia: analysis for mutations and identification of numerous pseudogenes. Eur Heart J. 2004; 25: 66\u201366.Abstract.","journal-title":"Eur Heart J"},{"key":"e_1_3_2_38_2","first-page":"492","volume":"116","year":"2007","unstructured":"Ruan Y, Theilade J, Memmi M, Giuli LD, Rizzi N, Cruz FE, Napolitano C, Priori SG. KCNJ2 mutations in patients referred for catecholaminergic polymorphic ventricular tachycardia gene screening. Circulation. 2007; 116: 492\u2013492.","journal-title":"Circulation"}],"container-title":["Circulation: Arrhythmia and Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/CIRCEP.109.872309","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T23:50:13Z","timestamp":1715557813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCEP.109.872309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["10.1161\/CIRCEP.109.872309"],"URL":"https:\/\/doi.org\/10.1161\/circep.109.872309","relation":{},"ISSN":["1941-3149","1941-3084"],"issn-type":[{"value":"1941-3149","type":"print"},{"value":"1941-3084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10]]},"assertion":[{"value":"2009-08-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}